150 related articles for article (PubMed ID: 38774475)
41. The nocebo effect: patient expectations and medication side effects.
Faasse K; Petrie KJ
Postgrad Med J; 2013 Sep; 89(1055):540-6. PubMed ID: 23842213
[TBL] [Abstract][Full Text] [Related]
42. Impact of Appointment-Based Medication Synchronization on Existing Users of Chronic Medications.
Holdford D; Saxena K
J Manag Care Spec Pharm; 2015 Aug; 21(8):662-9. PubMed ID: 26233538
[TBL] [Abstract][Full Text] [Related]
43. How does the side-effect information in patient information leaflets influence peoples' side-effect expectations? A cross-sectional national survey of 18- to 65-year-olds in England.
Webster RK; Weinman J; Rubin GJ
Health Expect; 2017 Dec; 20(6):1411-1420. PubMed ID: 28618140
[TBL] [Abstract][Full Text] [Related]
44. Adherence and Persistence with DPP-4 Inhibitors Versus Pioglitazone in Type 2 Diabetes Patients with Chronic Kidney Disease: A Retrospective Claims Database Analysis.
Gor D; Lee TA; Schumock GT; Walton SM; Gerber BS; Nutescu EA; Touchette DR
J Manag Care Spec Pharm; 2020 Jan; 26(1):67-75. PubMed ID: 31880221
[TBL] [Abstract][Full Text] [Related]
45. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
[TBL] [Abstract][Full Text] [Related]
46. Health Beliefs and Medication Adherence in Omanis With Hypertension.
Al-Noumani H; Wu JR; Barksdale D; Knafl G; AlKhasawneh E; Sherwood G
J Cardiovasc Nurs; 2018; 33(6):518-526. PubMed ID: 30130358
[TBL] [Abstract][Full Text] [Related]
47. Qualitative Analysis of Factors Influencing Patient Persistence and Adherence to Prescribed Overactive Bladder Medication in UK Primary Care.
Ali M; Grogan S; Powell S; Staniford L; Nazir J; Landeira M; Covernton PJO; Jaggi A; Fatoye F; Holt M
Adv Ther; 2019 Nov; 36(11):3110-3122. PubMed ID: 31559603
[TBL] [Abstract][Full Text] [Related]
48. The Association Among Medication Beliefs, Perception of Illness and Medication Adherence in Ischemic Stroke Patients: A Cross-Sectional Study in China.
Ruksakulpiwat S; Liu Z; Yue S; Fan Y
Patient Prefer Adherence; 2020; 14():235-247. PubMed ID: 32103908
[TBL] [Abstract][Full Text] [Related]
49. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
[TBL] [Abstract][Full Text] [Related]
50. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
Mathews R; Wang TY; Honeycutt E; Henry TD; Zettler M; Chang M; Fonarow GC; Peterson ED;
Am Heart J; 2015 Jul; 170(1):62-9. PubMed ID: 26093865
[TBL] [Abstract][Full Text] [Related]
51. Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder.
Emilsson M; Gustafsson PA; Öhnström G; Marteinsdottir I
Eur Child Adolesc Psychiatry; 2017 May; 26(5):559-571. PubMed ID: 27848023
[TBL] [Abstract][Full Text] [Related]
52. Predicting Adherence and Persistence with Oral Bisphosphonate Therapy in an Integrated Health Care Delivery System.
Hui RL; Adams AL; Niu F; Ettinger B; Yi DK; Chandra M; Lo JC
J Manag Care Spec Pharm; 2017 Apr; 23(4):503-512. PubMed ID: 28345435
[TBL] [Abstract][Full Text] [Related]
53. Unintentional non-adherence to chronic prescription medications: how unintentional is it really?
Gadkari AS; McHorney CA
BMC Health Serv Res; 2012 Jun; 12():98. PubMed ID: 22510235
[TBL] [Abstract][Full Text] [Related]
54. Beliefs that influence cost-related medication non-adherence among the "haves" and "have nots" with chronic diseases.
Piette JD; Beard A; Rosland AM; McHorney CA
Patient Prefer Adherence; 2011; 5():389-96. PubMed ID: 21949602
[TBL] [Abstract][Full Text] [Related]
55. Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study.
Pan Y; Heisig SR; von Blanckenburg P; Albert US; Hadji P; Rief W; Nestoriuc Y
Breast Cancer Res Treat; 2018 Apr; 168(3):667-677. PubMed ID: 29330625
[TBL] [Abstract][Full Text] [Related]
56. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
57. Patient-reported reasons for discontinuing overactive bladder medication.
Benner JS; Nichol MB; Rovner ES; Jumadilova Z; Alvir J; Hussein M; Fanning K; Trocio JN; Brubaker L
BJU Int; 2010 May; 105(9):1276-82. PubMed ID: 19912188
[TBL] [Abstract][Full Text] [Related]
58. Delay in filling the initial prescription for a statin: a potential early indicator of medication nonpersistence.
Yu AP; Yu YF; Nichol MB; Gwadry-Sridhar F
Clin Ther; 2008 Apr; 30(4):761-74; discussion 716. PubMed ID: 18498924
[TBL] [Abstract][Full Text] [Related]
59. Concerns and beliefs about medicines and inappropriate medications: An Internet-based survey on risk factors for self-reported adverse drug events among older adults.
Shiyanbola OO; Farris KB
Am J Geriatr Pharmacother; 2010 Jun; 8(3):245-57. PubMed ID: 20624614
[TBL] [Abstract][Full Text] [Related]
60. Effect of different methods for estimating persistence and adherence to new glucose-lowering drugs: results of an observational, inception cohort study in Portugal.
Torre C; Guerreiro J; Longo P; Raposo JF; Leufkens H; Martins AP
Patient Prefer Adherence; 2018; 12():1471-1482. PubMed ID: 30147305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]